How to manage patients on benzodiazepines and Z-drugs during the COVID 19 pandemic, NIHR
Benzodiazepines and Z-drugs (Zopiclone and Zolpidem) have the capacity to depress respiratory drive, so they should be used with caution in patients with evidence of compromised respiratory function (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

NIHR Alert: Public health messages on alcohol need to consider how and why people drink, not just how much, NIHR Evidence
Commentaries are provided on interviews conducted on 22 adults in North East England. Researchers found that people often thought harmful drinking was less about the quantity consumed and more about a person ' s emotional relationship with alcohol. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 24, 2020 Category: Consumer Health News Source Type: news

UK to launch world's largest genetic study into chronic fatigue syndrome
Research aims to shine a light on condition that is believed to affect 250,000 people in UKThe world ’s largest genetic study into chronic fatigue syndrome is to be launched in the UK after receiving £3.2m of funding from the Medical Research Council and National Institute for Health Research.The research aims to shine a light on the debilitating long-term condition, about which little is known, by collecting DNA samples from 20,000 people who have CFS, also known as myalgic encephalomyelitis (ME).Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 22, 2020 Category: Science Authors: Haroon Siddique Tags: ME / Chronic fatigue syndrome Medical research Health Science UK news Society Source Type: news

First volunteer receives new COVID-19 vaccine today
The first healthy volunteer has now received a new coronavirus vaccine developed by researchers led by Professor Robin Shattock at Imperial College London. The phase I trials were funded by UKRI as part of the UKRI/DHSC/NIHR COVID-19 rapid research response. (Source: Medical Research Council General News)
Source: Medical Research Council General News - June 22, 2020 Category: Research Source Type: news

First drug to reduce mortality in hospitalised patients with respiratory complications of COVID-19 found, NIHR: Oxford Health Biomedical Research Centre
The NIHR-funded and supported study RECOVERY (Randomised Evaluation of COVid-19 thERapY) has today announced that the steroid dexamethasone has been identified as the first drug to improve survival rates in certain coronavirus patients. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 17, 2020 Category: Consumer Health News Source Type: news

Therapists and patients have good quality interactions during telephone sessions, NIHR: Oxford Health Biomedical Research Centre
The quality of interactions between therapists and their patients is as good by telephone as in face-to-face sessions. A review of the evidence found little difference in the interaction regardless of how therapy was delivered. Telephone sessions were shorter but measures such as empathy and attentiveness, as well as patients ' readiness to disclose information, was similar in both settings. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 17, 2020 Category: Consumer Health News Source Type: news

UKRI and NIHR move to new phase of COVID-19 research funding
To meet the needs of this new environment, the NIHR/UKRI rolling call will close to new applications on 30 June 2020. The NIHR has launched a new‘Recovery and Learning’ callto better understand and manage the health and social care consequences of the global COVID-19 pandemic. (Source: Medical Research Council General News)
Source: Medical Research Council General News - June 16, 2020 Category: Research Source Type: news

COVID-19 & clinical management of mental health issues, NIHR: Oxford Health Biomedical Research Centre
Summary of the best available guidance about key COVID-19 questions that frontline mental health clinicians are facing every day. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 15, 2020 Category: Consumer Health News Source Type: news

Guide to COVID-19 clinical evidence generation launched by NIHR and NICE
The NIHR and NICE have developed a guide on clinical evidence generation for developers of medicinal products for COVID-19. The aim is to promote the highest standards possible within the constraints of the pandemic in terms of registration, conduct and reporting of studies, so that research on new treatments can be translated into clinical practice as fast as possible. The guide covers both confirmatory trials and real-world evidence collection on disease treatment and prevention, outlining the best practice approaches to a range of issues including trial design, population identification, the length of the trial and tria...
Source: Current Awareness Service for Health (CASH) - June 12, 2020 Category: Consumer Health News Source Type: news

Research begins to rapidly understand deadly link between Covid-19 and cardiovascular diseases
Improved care for people with heart and circulatory disease suffering from COVID-19 could soon be available after the British Heart Foundation (BHF) and National Institute for Health Research (NIHR) announced support for six flagship research programmes. Researchers from across the UK including the University of Bristol will combine data from hospitals, information about our health and lifestyle, genetic studies, and cutting-edge imaging and artificial intelligence techniques to better understand how the virus affects the heart and circulatory system. (Source: University of Bristol news)
Source: University of Bristol news - June 12, 2020 Category: Universities & Medical Training Tags: Research, Health, Grants and Awards; Institutes, ALSPAC, Institutes, Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

COVID-19 & clinical management of mental health issues , NIHR: Oxford Health Biomedical Research Centre
Summary of the best available guidance about key COVID-19 questions that frontline mental health clinicians are facing every day. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 8, 2020 Category: Consumer Health News Source Type: news

Social prescribing could empower patients to address non-medical problems in their lives, NIHR
NIHR Evidence. Many GP practices are exploring social prescribing, which is a way of linking patients to sources of support in the local community. Social prescribing addresses non-medical needs such as loneliness and financial difficulties. The NHS employs link workers to connect patients with local support networks. During the COVID-19 crisis, link workers may have an even greater role to play in supporting vulnerable patients who are isolated at home. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 29, 2020 Category: Consumer Health News Source Type: news

NIHR Alert: Largest ever trial into a rare cancer of the urinary system shows clear benefits of chemotherapy after surgery, NIHR Evidence
The largest trial ever conducted into the disease found that giving chemotherapy halves the risk of the cancer coming back after surgery. The results provide clear evidence for this approach to become the new standard of care for patients whose disease has not spread to other parts of the body. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 27, 2020 Category: Consumer Health News Source Type: news

£ 7 million government investment in Patient Recruitment Centres for commercial clinical research
(National Institute for Health Research) The new research centres will increase capacity within the NHS to deliver vital research for patients, while decreasing the time it takes to set-up late-phase commercial trials within the NHS -- improving the UK's competitiveness in the global market and providing opportunities for patients to benefit from early access to innovation. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 22, 2020 Category: Infectious Diseases Source Type: news